Slide

NEWS & PRESS


All News & Press

January 3, 2024

CordenPharma & pHLIP Announce Strategic Alliance to Develop pHLIP LNP Targeted Delivery Platform

4 Jan, 2024
Press Release > CordenPharma & pHLIP Announce Strategic Alliance to Develop pHLIP LNP Targeted Delivery Platform
October 9, 2023

CDMO Financial Resilience Through Technology & Investment

Edition 3 / October 2023
Editorial > Financial Resilience Through Innovative Technology & Strategic Investment
October 9, 2023

Technology & Science Advisory Board Kickoff Meeting

Edition 3 / October 2023
TSAB > CordenPharma’s Technology & Science Advisory Board Meeting Kickoff
October 9, 2023

Drug Product Innovation Centre Optimizes APIs & OSD Formulations

Edition 3 / October 2023
Early-Phase Drug Products > Drug Product Innovation Centre Targets Optimal API Modifications & OSD Formulations
October 9, 2023

Meet CordenPharma at CPHI Barcelona, AAPS PharmSci 360 & Tides Europe in 2023

Edition 3 / October 2023
Meet CordenPharma at CPHI Barcelona, AAPS or Tides Europe
September 5, 2023

CordenPharma Inaugurates Increased Peptide Production of Largest Worldwide SPPS Manufacturing Plant

6 September, 2023
Press Release > CordenPharma Inaugurates Increased Peptide Production of Largest Worldwide SPPS Manufacturing Plant
July 25, 2023

CordenPharma Establishes Technology & Science Advisory Board of Experts

July 26, 2023
Press Release > CordenPharma Establishes Technology & Science Advisory Board of Experts Across our 6 Platforms.
June 27, 2023

A Look Inside CordenPharma’s Global People Strategy

Edition 2 / June 2023
Editorial > People-Centred Culture: CordenPharma’s New Global People Strategy
June 27, 2023

CordenPharma Re-Enters Synthetic Oligonucleotide Manufacturing Space

Edition 2 / June 2023
Oligonucleotides Platforms > Never Say Never: CordenPharma Oligos Are Back!
June 27, 2023

Project AIRMAIL: Using AI for LNP Formulation of RNA & DNA Actives

Edition 2 / June 2023
Lipids & Carbohydrates Platforms > Project AIRMAIL – Artificial Intelligence In Drug Development: Machine Learning Algorithm For The LNP Formulation Of RNA & DNA Actives
June 27, 2023

CordenPharma Bergamo’s State-of-the-Art API Development Building

Edition 2 / June 2023
Timelapse Video > New API Development Building at CordenPharma Bergamo
May 25, 2023

CEO Michael Quirmbach Talks on 2023 Capex Investments in Oligonucleotides, Peptides & LNP Formulation

May 25, 2023
Global Business Reports Interview: CEO Michael Quirmbach Talks on 2023 Capex Investments in Oligonucleotides, Peptides & LNP Formulation
May 1, 2023

CordenPharma Announces Entry into Oligonucleotide API Manufacturing

May 2, 2023
Press Release > CordenPharma Announces Entry into Oligonucleotide Manufacturing at CordenPharma Colorado.
April 23, 2023

CordenPharma Opens Drug Product Innovation Centre of Excellence with the Addition of Bioavailability Enhancement

April 23, 2023
CordenPharma Opens Early Phase Drug Product Innovation Centre of Excellence with Bioavailability Enhancement Technologies.
March 30, 2023

WACKER, CordenPharma, LMU & HU Berlin Train AI Machine-Learning Algorithm for Formulation of RNA Actives

March 30, 2023
Press Release > Wacker & CordenPharma Develop LNPs to Train AI Machine-Learning Algorithm for the Formulation of RNA Actives